{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:03:10Z","timestamp":1781521390960,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12325-025-03466-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:44:45Z","timestamp":1769499885000},"page":"1239-1254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn\u2019s Disease and their Role in Patients with Low-Risk Features"],"prefix":"10.1007","volume":"43","author":[{"given":"Angelo","family":"Del Gaudio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Privitera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Laterza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris Riccardo","family":"Lopetuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Scaldaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-5402","authenticated-orcid":false,"given":"Daniela","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"6","key":"3466_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ibd.21506","volume":"17","author":"B Pariente","year":"2011","unstructured":"Pariente B, Cosnes J, Danese S, et al. Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann score. Inflamm Bowel Dis. 2011;17(6):1415\u201322.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"3466_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/bjs.11659","volume":"107","author":"TD Kalman","year":"2020","unstructured":"Kalman TD, Everhov \u00c5H, Nordenvall C, et al. Decrease in primary but not in secondary abdominal surgery for Crohn\u2019s disease: nationwide cohort study, 1990\u20132014. Br J Surg. 2020;107(11):1529\u201338.","journal-title":"Br J Surg"},{"issue":"1","key":"3466_CR3","first-page":"1","volume":"12","author":"WA Bemelman","year":"2018","unstructured":"Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO\u2011ESCP consensus on surgery for Crohn\u2019s disease. J Crohns Colitis. 2018;12(1):1\u201316.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3466_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","volume":"145","author":"AD Frolkis","year":"2013","unstructured":"Frolkis AD, Dykeman J, Negr\u00f3n ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145(5):996\u20131006.","journal-title":"Gastroenterology"},{"issue":"9976","key":"3466_CR5","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","volume":"385","author":"P De Cruz","year":"2015","unstructured":"De Cruz P, Kamm MA, Hamilton AL, et al. Crohn\u2019s disease management after intestinal resection: a randomised trial. Lancet. 2015;385(9976):1406\u201317.","journal-title":"Lancet"},{"key":"3466_CR6","doi-asserted-by":"publisher","first-page":"175628482199358","DOI":"10.1177\/1756284821993581","volume":"14","author":"RS Shah","year":"2021","unstructured":"Shah RS, Click BH, et al. Medical therapies for postoperative Crohn\u2019s disease. Therap Adv Gastroenterol. 2021;14:1756284821993581.","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"3466_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izab044","volume":"28","author":"V Joustra","year":"2022","unstructured":"Joustra V, Duijvestein M, Mookhoek A, et al. Natural history and risk stratification of recurrent Crohn\u2019s disease after ileocolonic resection: a multicenter retrospective cohort study. Inflamm Bowel Dis. 2022;28(1):1\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"3466_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113(4):481\u2013517.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3466_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology. 1990;99(4):956\u201363.","journal-title":"Gastroenterology"},{"issue":"2","key":"3466_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn\u2019s disease. Gastroenterology. 2002;122(2):512\u201330.","journal-title":"Gastroenterology"},{"issue":"33","key":"3466_CR11","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.3748\/wjg.14.5540","volume":"14","author":"P Nos","year":"2008","unstructured":"Nos P, Dom\u00e8nech E, et al. Postoperative Crohn\u2019s disease recurrence: a practical approach. World J Gastroenterol. 2008;14(33):5540\u20138.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3466_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.14309\/ajg.0000000000002509","volume":"119","author":"MTJ Bak","year":"2024","unstructured":"Bak MTJ, Ten Bokkel Huinink S, Erler NS, et al. Prognostic value of the modified Rutgeerts score for long-term outcomes after primary ileocecal resection in Crohn\u2019s disease. Am J Gastroenterol. 2024;119(2):306\u201312.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3466_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/ecco-jcc\/jjac137","volume":"17","author":"P Rivi\u00e8re","year":"2023","unstructured":"Rivi\u00e8re P, Pekow J, Hammoudi N, et al. Comparison of the risk of Crohn\u2019s disease postoperative recurrence between modified Rutgeerts score i2a and i2b categories: an individual patient data meta\u2011analysis. J Crohns Colitis. 2023;17(2):269\u201376.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"3466_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ibd\/izab134","volume":"28","author":"P De Cruz","year":"2022","unstructured":"De Cruz P, Hamilton AL, Burrell KJ, et al. Endoscopic prediction of Crohn\u2019s disease postoperative recurrence. Inflamm Bowel Dis. 2022;28(4):680\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"3466_CR15","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/ecco-jcc\/jjad116","volume":"17","author":"T Ueda","year":"2023","unstructured":"Ueda T, Koyama F, Sugita A, et al. Endoscopic lesions of postoperative anastomotic area in patients with Crohn\u2019s disease in the biologic era: a Japanese multi\u2011centre nationwide cohort study. J Crohns Colitis. 2023;17(12):1968\u201379.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3466_CR16","first-page":"749","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(5):749\u201353.","journal-title":"Gut"},{"issue":"4","key":"3466_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.MIB.0000215091.77492.2a","volume":"12","author":"WR Best","year":"2006","unstructured":"Best WR. Predicting the Crohn\u2019s disease activity index from the Harvey\u2011Bradshaw Index. Inflamm Bowel Dis. 2006;12(4):304\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"3466_CR18","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1007\/s10620-016-4215-1","volume":"61","author":"P Bayart","year":"2016","unstructured":"Bayart P, Duveau N, Nachury M, et al. Ileal or anastomotic location of lesions does not impact rate of postoperative recurrence in Crohn\u2019s disease patients classified i2 on the Rutgeerts score. Dig Dis Sci. 2016;61(10):2986\u201392.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"3466_CR19","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1007\/s10620-020-06599-3","volume":"66","author":"JY Kim","year":"2021","unstructured":"Kim JY, Park SH, Park JC, et al. The clinical significance of anastomotic ulcers after ileocolic resection to predict postoperative recurrence of Crohn\u2019s disease. Dig Dis Sci. 2021;66(12):3132\u201340.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3466_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.23922\/jarc.2020-088","volume":"5","author":"T Ueda","year":"2021","unstructured":"Ueda T, Koyama F, Nakamoto T, et al. Endoscopic features of postoperative anastomotic lesions in patients with Crohn\u2019s disease compared with right-side colon cancer: are anastomotic linear superficial ulcers recurrent in Crohn\u2019s disease? J Anus Rectum Colon. 2021;5(2):158\u201366.","journal-title":"J Anus Rectum Colon"},{"issue":"7","key":"3466_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.14309\/ajg.0000000000000638","volume":"115","author":"N Hammoudi","year":"2020","unstructured":"Hammoudi N, Auzolle C, Tran Minh ML, et al. Postoperative endoscopic recurrence on the neoterminal ileum but not on the anastomosis is mainly driving long-term outcomes in Crohn\u2019s disease. Am J Gastroenterol. 2020;115(7):1084\u201393.","journal-title":"Am J Gastroenterol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03466-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:30:24Z","timestamp":1773822624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03466-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3466"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03466-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Angelo Del Gaudio, Laura Parisio, Giuseppe Privitera, Giuseppe Cuccia, Gaetano Coppola and Luigi Carbone have nothing to disclose. Lucrezia Laterza received speakers and consulting fees from Abivax, Biocure, Abbvie, Lilly and Jannsen. Loris Riccardo Lopetuso received fees for conferences and boards: Abbvie, Alfasigma, Ferring, Lilly, Johnson & Johnson, Cadigroup, Institut Allegosan, Opella, Recordati. Alfredo Papa received speakers and consulting fees from Johnson & Johnson. Antonio Gasbarrini reports personal fees for consultancy for Eisai S.r.l., 3PSolutions, Real Time Meeting, Fondazione Istituto Danone, Sinergie. Board MRGE and Sanofi; personal fees for acting as a speaker for Takeda, AbbVie and Sandoz and personal fees for acting on advisory boards for VSL3 and Eisai. Franco Scaldaferri received speakers and consulting fees from Janseen, Takeda, Lilly, Sandoz, Celltrion, Alfa Sigma, MSD. Daniela Pugliese received speakers and consulting fees from AbbVie, MSD, Takeda, Pfizer, Alphasigma, Johnson. She is also an Editorial Board member of Advances in Therapy, but she was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This cohort was collected during routine medical care, and it is part of the study entitled \u201cEvaluation of the efficacy and safety of endoscopic dilation combined with biological therapy for the treatment of intestinal strictures in patients with Crohn\u2019s disease\u201d (Endo_Bio-Crohn, study ID 6815), Principal Investigator: Prof. Franco Scaldaferri. The study was approved on 08\/08\/2024 by the Territorial Ethics Committee Lazio Area 3. All enrolled patients signed informed consent to participate in the study. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}